2021 New Mexico Statutes
Article 1 - General Provisions
Section 26-1-8 - Minor violations of act; warnings authorized.

Nothing in the New Mexico Drug and Cosmetic Act [New Mexico Drug, Device and Cosmetic Act] shall be construed as requiring the board to report for the institution of proceedings, minor violations of the New Mexico Drug and Cosmetic Act [New Mexico Drug, Device and Cosmetic Act], whenever the board believes that the public interest will be adequately served in the circumstances by a suitable written notice or warning.
History: 1953 Comp., § 54-6-33, enacted by Laws 1967, ch. 23, § 8.
Bracketed material. — The bracketed material was inserted by the compiler and is not part of the law. Laws 1987, ch. 270, § 8 provided that references to the New Mexico Drug and Cosmetic Act shall be construed as references to the New Mexico Drug, Device and Cosmetic Act.

Structure 2021 New Mexico Statutes

2021 New Mexico Statutes

Chapter 26 - Drugs and Cosmetics

Article 1 - General Provisions

Section 26-1-1 - Short title.

Section 26-1-2 - Definitions.

Section 26-1-3 - Prohibited acts.

Section 26-1-3.1 - Repealed.

Section 26-1-3.2 - Prescription drug donation.

Section 26-1-4 - Power to enjoin violations.

Section 26-1-5 - Penalty; exemptions.

Section 26-1-6 - Detection of drugs, devices or cosmetic believed adulterated, misbranded or counterfeit; condemnation; destruction or correction of defect; forfeiture and sale.

Section 26-1-7 - Attorney general or district attorney to institute prosecutions.

Section 26-1-8 - Minor violations of act; warnings authorized.

Section 26-1-9 - Addition of poisonous or deleterious substances; color additives.

Section 26-1-10 - Drug or device adulteration.

Section 26-1-11 - Drug or device; misbranding.

Section 26-1-12 - False advertising.

Section 26-1-13 - Packaging and labeling requirements; proprietary preparations.

Section 26-1-14 - New drugs and devices; prerequisites to sale, delivery or giving away; exceptions.

Section 26-1-15 - Dangerous drugs; veterinary use; limitations.

Section 26-1-16 - Dangerous drugs; conditions for sale; prescription refilling; limitations.

Section 26-1-16.1 - Opioids; requiring practitioners to obtain and review reports from the prescription monitoring program.

Section 26-1-17 - Testing laboratory.

Section 26-1-18 - Promulgating regulations; procedure.

Section 26-1-18.1 - Prescription drug prior authorization protocols.

Section 26-1-19 - Power to make inspections and secure samples.

Section 26-1-20 - Personnel.

Section 26-1-21 - Power of board to publish reports and disseminate information.

Section 26-1-22 - Unlawful means of obtaining dangerous drugs enumerated.

Section 26-1-23 - False statements; false pretenses; forgery of labels or prescriptions prohibited.

Section 26-1-24 - Cosmetics; misbranding.

Section 26-1-25 - Cosmetics; adulteration.

Section 26-1-26 - Penalties.